Jie Shen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Placebo Controlled

Acute Lymphoblastic Leukemia

Electronic Health Record

Diffuse Large B Cell Lymphoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of zeste homolog 2 inhibitor SHR2554 in relapsed or refractory peripheral T-cell lymphoma: data from the first-in-human phase 1 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)